Hepion Pharmaceuticals, Inc. (HEPA)
HEPA Stock Price Chart
Explore Hepion Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze HEPA price movements and trends.
HEPA Company Profile
Discover essential business fundamentals and corporate details for Hepion Pharmaceuticals, Inc. (HEPA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 Feb 2014
Employees
22.00
Website
https://www.hepionpharma.comCEO
John Patrick Brancaccio CPA
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH), as well as in nonclinical studies to reduce liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH, and has demonstrated antiviral activities towards hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.
HEPA Financial Timeline
Browse a chronological timeline of Hepion Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Apr 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 11 Aug 2025
EPS came in at -$0.09 .
Earnings released on 19 May 2025
EPS came in at -$2.15 .
Earnings released on 8 Apr 2025
EPS came in at -$11.12 surpassing the estimated -$98.50 by +88.71%.
Stock split effective on 18 Mar 2025
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2024
EPS came in at -$36.00 surpassing the estimated -$95.00 by +62.11%.
Earnings released on 13 Aug 2024
EPS came in at -$34.00 surpassing the estimated -$185.50 by +81.67%.
Earnings released on 16 Apr 2024
EPS came in at -$121.00 surpassing the estimated -$131.50 by +7.98%.
Earnings released on 25 Mar 2024
EPS came in at -$2.42 surpassing the estimated -$2.63 by +7.98%, while revenue for the quarter reached $109.73K .
Earnings released on 20 Nov 2023
EPS came in at -$137.00 falling short of the estimated -$134.00 by -2.24%.
Earnings released on 14 Aug 2023
EPS came in at -$184.00 falling short of the estimated -$3.32 by -5.44K%.
Earnings released on 12 May 2023
EPS came in at -$174.00 falling short of the estimated -$3.60 by -4.73K%.
Stock split effective on 11 May 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Apr 2023
EPS came in at -$0.13 matching the estimated -$0.13.
Earnings released on 14 Nov 2022
EPS came in at -$110.00 falling short of the estimated -$0.17 by -64.61K%.
Earnings released on 15 Aug 2022
EPS came in at -$0.26 falling short of the estimated -$0.12 by -116.67%.
Earnings released on 8 Apr 2022
EPS came in at -$0.13 falling short of the estimated -$0.12 by -8.33%.
Earnings released on 3 Jan 2022
EPS came in at -$2.55 .
Earnings released on 15 Nov 2021
EPS came in at -$120.00 falling short of the estimated -$0.19 by -63.06K%.
Earnings released on 16 Aug 2021
EPS came in at -$100.00 .
Earnings released on 14 May 2021
EPS came in at -$120.00 falling short of the estimated -$0.20 by -59.90K%.
Earnings released on 31 Mar 2021
EPS came in at -$0.29 falling short of the estimated -$0.20 by -45.00%.
Earnings released on 16 Nov 2020
EPS came in at -$690.00 falling short of the estimated -$510.00 by -35.29%.
HEPA Stock Performance
Access detailed HEPA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.